Indapamide
اینداپامید
❤️ Cardiovascular SystemThiazide-like diuretic
Market / country: 🇬🇧 UK
Natrilix (GB)
🧮 Dose calculator
Hypertension · Regimen source: UK SmPC Indapamide · 4.2
- • Higher doses not recommended (no added antihypertensive effect). Full effect may take months. UK SmPC Indapamide · 4.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to indapamide or sulfonamides; severe renal or hepatic failure; hypokalaemia; porphyria; Addison's disease; refractory hyponatraemia or hypercalcaemia. UK SmPC Indapamide · 4.3
- ⛔ No pediatric dose in this SmPC. UK SmPC Indapamide · 4.2
Formulations
- 2.5 mg coated tablet — tablet 🇬🇧 UK UK SmPC Indapamide · 2
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. UK SmPC Indapamide · 4.6
“There are no or limited amount of data (less than 300 pregnancy outcomes) from the use of indapamide in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. UK SmPC Indapamide · 4.6
“Indapamide is excreted in human milk in small amounts.Hypersensitivity to sulfonamide-derived medicines and hypokalaemia might occur.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. UK SmPC Indapamide · 4.2
“Paediatric population: Indapamide is not recommended for use in children and adolescents due to a lack of data on safety and efficacy.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. UK SmPC Indapamide · 4.2
“Elderly (see section 4.4): In the elderly, the plasma creatinine must be adjusted in relation to age, weight and gender.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)❌ None
- DailyMed (FDA label)❌ None
- MedlinePlus (NIH)Indapamide
- WHO ATC/DDDC03BA11
- Darooyab (Iran)Indapamide
- eMC (UK label)UK SmPC Indapamide
🇮🇷 Registered in Iran Darooyab · G-1713/Indapamide
Dosage forms with Iranian generic codes, per Darooyab.
- 05637 · INDAPAMIDE 1.5MG TAB · قرص اینداپامید ۱٫۵ میلیگرم
- 52031 · INDAPAMIDE TABLET ORAL 2.5 mg · قرص اینداپامید ۲٫۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)❌ Not present
- UK SmPC (eMC / MHRA)✅ PresentUK SmPC Indapamide · 2UK SmPC Indapamide · 4.2UK SmPC Indapamide · 4.3UK SmPC Indapamide · 4.6
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1713/Indapamide
- Clinical review⚠ Unverified